Company Overview of Potentia Pharmaceuticals, Inc.
Potentia Pharmaceuticals, Inc., a biotechnology company, develops anti-inflammatory drugs/therapeutics for chronic inflammatory diseases in patients. The company develops drugs for age-related macular degeneration, atherosclerosis, uveitis, rheumatoid arthritis, multiple sclerosis, and Alzheimer's diseases. It serves customers in the United States. The company was founded in 2001 and is based in Crestwood, Kentucky. As of November 20, 2015, Potentia Pharmaceuticals, Inc. operates as a subsidiary of Apellis Pharmaceuticals, Inc.
6400 Westwind Way
Crestwood, KY 40014
Founded in 2001
Key Executives for Potentia Pharmaceuticals, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact Potentia Pharmaceuticals, Inc., please visit www.potentiapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.